Tower Research Capital LLC (TRC) - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 19 filers reported holding AVENUE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,000
-93.3%
3,135
-90.2%
0.00%
Q1 2022$15,000
-21.1%
32,068
+48.9%
0.00%
Q4 2021$19,000
-24.0%
21,530
+28.9%
0.00%
-100.0%
Q3 2021$25,000
-13.8%
16,704
+46.9%
0.00%0.0%
Q2 2021$29,000
+70.6%
11,373
+304.9%
0.00%
Q1 2021$17,000
-65.3%
2,809
-65.8%
0.00%
-100.0%
Q4 2020$49,000
-34.7%
8,222
+19.1%
0.00%0.0%
Q3 2020$75,000
+44.2%
6,906
+43.0%
0.00%
-50.0%
Q2 2020$52,000
+5100.0%
4,830
+3325.5%
0.00%
Q1 2020$1,000
-50.0%
141
-65.4%
0.00%
Q1 2019$2,0000.0%408
-34.8%
0.00%
Q2 2018$2,000
-95.1%
626
-91.5%
0.00%
-100.0%
Q3 2017$41,0007,3250.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
EMFO, LLC 24,000$12,0000.01%
Virtu Financial LLC 58,004$28,0000.00%
TWO SIGMA SECURITIES, LLC 52,813$25,0000.00%
B. Riley Wealth Advisors, Inc. 60,330$30,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$4,0000.00%
BANK OF AMERICA CORP /DE/ 104$00.00%
WELLS FARGO & COMPANY/MN 48,062$23,0000.00%
NORTHERN TRUST CORP 13,767$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$40,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders